Popkin D R
Can Med Assoc J. 1979 May 5;120(9):1106-8.
Ovarian cancer is the most common fatal gynecologic malignant disease. Unfortunately 60% to 70% of patients present initially with advanced disease. Progress in the treatment of this condition will be made only if it can be diagnosed early. Pelvic examination is still the best screening test despite attempts to make an early diagnosis with the use of cytology, ultrasonography, and serum determinations for fibrin degradation product; haptoglobin, protein-bound fucose and tumour-associated antigens. The best prospect for a screening test for ovarian cancer probably lies in the field of tumour immunology.
卵巢癌是最常见的致命性妇科恶性疾病。不幸的是,60%至70%的患者初诊时即为晚期疾病。只有早期诊断,这种疾病的治疗才会取得进展。尽管有人尝试通过细胞学、超声检查以及检测纤维蛋白降解产物、触珠蛋白、蛋白结合岩藻糖和肿瘤相关抗原的血清测定来进行早期诊断,但盆腔检查仍是最佳的筛查方法。卵巢癌筛查试验最有前景的领域可能在于肿瘤免疫学。